Quinolone Resistance Mechanisms in Pneumococci
Open Access
- 15 May 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (Supplement) , S350-S356
Abstract
Quinolones are widely used in the treatment of respiratory infections, in large part because of their activity against Streptococcus pneumoniae and oKeywords
This publication has 34 references indexed in Scilit:
- Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent AdultsClinical Infectious Diseases, 2003
- Fluoroquinolone resistance among Gram-positive cocciThe Lancet Infectious Diseases, 2002
- Longitudinal Assessment of Antipneumococcal Susceptibility in the United StatesAntimicrobial Agents and Chemotherapy, 2002
- Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in Canada during 2000Antimicrobial Agents and Chemotherapy, 2002
- Mechanism of plasmid-mediated quinolone resistanceProceedings of the National Academy of Sciences, 2002
- Fluoroquinolone Resistance in Streptococcus pneumoniae in United States since 1994-1995Antimicrobial Agents and Chemotherapy, 2002
- Guidelines for the Management of Adults with Community-acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal AnalysisAntimicrobial Agents and Chemotherapy, 2001
- Engineering the Specificity of Antibacterial Fluoroquinolones: Benzenesulfonamide Modifications at C-7 of Ciprofloxacin Change Its Primary Target in Streptococcus pneumoniae from Topoisomerase IV to GyraseAntimicrobial Agents and Chemotherapy, 2000
- Mechanisms of fluoroquinolone resistanceDrug Resistance Updates, 1999